1. NCCN Roundtable: palliative care: providing comfort from a patient and provider perspective. J Natl Compr Canc Netw 2016;14(Suppl 5):634–636.
Google Scholar | Medline2. Chang, EH . New insights into the pathogenesis of cystic fibrosis sinusitis. Int Forum Allergy Rhinol. 2014;4(2):132–137.
Google Scholar | Crossref | Medline3. Liang, J, Higgins, T, Ishman, SL, Boss, EF, Benke, JR, Lin, SY. Medical management of chronic rhinosinusitis in cystic fibrosis: a systematic review. Laryngoscope. 2014;124(6):1308–1313.
Google Scholar | Crossref | Medline4. Henriquez, OA, Wolfenden, LL, Stecenko, A, Delgaudio, JM, Wise, SK. Endoscopic sinus surgery in adults with cystic fibrosis: effect on lung function, intravenous antibiotic use, and hospitalization. Arch Otolaryngol Head Neck Surg. 2012;138(12):1167–1170.
Google Scholar | Crossref | Medline5. Macdonald, KI, Gipsman, A, Magit, A, et al. Endoscopic sinus surgery in patients with cystic fibrosis: a systematic review and meta-analysis of pulmonary function. Rhinology. 2012;50(4):360–369.
Google Scholar | Crossref | Medline6. Ramos, KJ, Pilewski, JM, Faro, A, Marshall, BC. Improved prognosis in cystic fibrosis: consideration for intensive care during the COVID-19 pandemic. Am J Respir Crit Care Med. 2020;201(11):1434–1435.
Google Scholar | Crossref | Medline7. Cystic Fibrosis Foundation Patient Registry, 2016 Annual Report. Bethesda, MD:61.
Google Scholar8. Utah Population Database . Huntsman Cancer Institute. https://uofuhealth.utah.edu/huntsman/utah-population-database/.Accessed October 30, 2020.
Google Scholar9. Oakley, GM, Curtin, K, Orb, Q, Schaefer, C, Orlandi, RR, Alt, JA. Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment. Int Forum Allergy Rhinol. 2015;5(4):276–282.
Google Scholar | Crossref | Medline10. Sweezey, NB, Ratjen, F. The cystic fibrosis gender gap: potential roles of estrogen. Pediatr Pulmonol. 2014;49(4):309–317.
Google Scholar | Crossref | Medline11. Harness-Brumley, CL, Elliott, AC, Rosenbluth, DB, Raghavan, D, Jain, R. Gender differences in outcomes of patients with cystic fibrosis. J Womens Health (Larchmt). 2014;23(12):1012–1020.
Google Scholar | Crossref | Medline12. Zemke, AC, Nouraie, SM, Moore, J, et al. Clinical predictors of cystic fibrosis chronic rhinosinusitis severity. Int Forum Allergy Rhinol. 2019;9(7):759–765.
Google Scholar | Crossref | Medline13. Rickert, S, Banuchi, VE, Germana, JD, Stewart, MG, April, MM. Cystic fibrosis and endoscopic sinus surgery: relationship between nasal polyposis and likelihood of revision endoscopic sinus surgery in patients with cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2010;136(10):988–992.
Google Scholar | Crossref | Medline14. Moss, RB, King, VV. Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery. Arch Otolaryngol Head Neck Surg. 1995;121(5):566–572.
Google Scholar | Crossref | Medline15. Skolnik, K, Quon, BS. Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations. F1000Res. 2018;7.
Google Scholar | Crossref | Medline16. Bilton, D, Canny, G, Conway, S, et al. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros. 2011;10(Suppl 2):S79–S81.
Google Scholar | Crossref | Medline17. Liou, TG, Adler, FR, Fitzsimmons, SC, Cahill, BC, Hibbs, JR, Marshall, BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001;153(4):345–352.
Google Scholar | Crossref | Medline18. Mainz, JG, Schien, C, Schiller, I, et al. Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trial. J Cyst Fibros. 2014;13(4):461–470.
Google Scholar | Crossref | Medline19. Illing, EA, Woodworth, BA. Management of the upper airway in cystic fibrosis. Curr Opin Pulm Med. 2014;20(6):623–631.
Google Scholar | Crossref | Medline20. Nishioka, GJ, Barbero, GJ, Konig, P, Parsons, DS, Cook, PR, Davis, WE. Symptom outcome after functional endoscopic sinus surgery in patients with cystic fibrosis: a prospective study. Otolaryngol Head Neck Surg. 1995;113(4):440–445.
Google Scholar | SAGE Journals21. Keck, T, Rozsasi, A. Medium-term symptom outcomes after paranasal sinus surgery in children and young adults with cystic fibrosis. Laryngoscope. 2007;117(3):475–479.
Google Scholar | Crossref | Medline22. Khalid, AN, Mace, J, Smith, TL. Outcomes of sinus surgery in adults with cystic fibrosis. Otolaryngol Head Neck Surg. 2009;141(3):358–363.
Google Scholar | SAGE Journals23. Khalfoun, S, Tumin, D, Ghossein, M, Lind, M, Hayes, D, Kirkby, S. Improved lung function after sinus surgery in cystic fibrosis patients with moderate obstruction. Otolaryngol Head Neck Surg. 2018;158(2):381–385.
Google Scholar | SAGE Journals24. Smith, KA, Orlandi, RR, Oakley, G, Meeks, H, Curtin, K, Alt, JA. Long-term revision rates for endoscopic sinus surgery. Int Forum Allergy Rhinol. 2019;9(4):402–408.
Google Scholar | Crossref | Medline25. Wu, AW, Ting, JY, Platt, MP, Tierney, HT, Metson, R. Factors affecting time to revision sinus surgery for nasal polyps: a 25-year experience. Laryngoscope. 2014;124(1):29–33.
Google Scholar | Crossref | Medline26. Crockett, DJ, Wilson, KF, Meier, JD. Perioperative strategies to improve sinus surgery outcomes in patients with cystic fibrosis: a systematic review. Otolaryngol Head Neck Surg. 2013;149(1):30–39.
Google Scholar | SAGE Journals27. Zheng, Z, Safi, C, Gudis, DA. Surgical management of chronic rhinosinusitis in cystic fibrosis. Med Sci (Basel). 2019;7(4):57
Google Scholar28. FDA approves new breakthrough therapy for cystic fibrosis. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-new-breakthrough-therapy-cystic-fibrosis?utm_campaign=102119_PR_FDA%20approves%20new%20breakthrough%20therapy%20for%20cystic%20fibrosis&utm_medium=email&utm_source=Eloqua. Accessed November 12, 2020.
Google Scholar29. DiMango, E, Spielman, DB, Overdevest, J, et al. Effect of highly effective modulator therapy on quality of life in adults with cystic fibrosis. Int Forum Allergy Rhinol. 2021;11(1):75–78.
Google Scholar | Crossref | Medline